Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04375891 · ClinicalTrials.gov registry record · NA
Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation
A NA study of Oncology and Spine Metastases, sponsored by Baptist Health South Florida.
- Active
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT04375891: Active NA study of Oncology and Spine Metastases, sponsored by Baptist Health South Florida.
NCT04375891 is a NA study of Oncology and Spine Metastases that is active but no longer recruiting, run by Baptist Health South Florida. The registered enrollment target is 63 participants, below the 525-participant average among 24 other Oncology trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04375891, a NA study of Oncology and Spine Metastases, is active but no longer recruiting, sponsored by Baptist Health South Florida.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
The spread of cancer to the spine is referred to as spine metastasis. Spine metastases are a common complication of cancer and are frequently associated with significant back pain. This study is being done to help improve treatment for back pain caused by spinal metastases by comparing the effectiveness of two standard treatments. These two treatments include radiation therapy (RT) alone versus radiation therapy combined with radiofrequency ablation, with or without vertebral augmentation (PVA/RFA). In addition to RT or RT with PVA/RFA, will be continued with current pain medications.
Primary Outcome
Change in pain control (as measured by the 11 point Numeric pain rating scale) as compared to conventional palliative radiotherapy alone.
Conditions Studied
Interventions
- RADIATION Radiation Therapy
- RADIATION Radiofrequency Ablation (RFA)
Study Locations (1)
Florida
- Miami Cancer Institute at Baptist Health South Florida - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2020-05-22 |
| Est. Completion | 2027-07 |
| Phase | NA |
What the registry record for NCT04375891 still lists
NCT04375891 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 525-participant average among 24 other Oncology trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Oncology appearing as the primary indexed condition, and to 2 interventions - of which Radiation Therapy is the first listed.
NCT04375891 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04375891 about?
NCT04375891 is a clinical study titled "Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation". The spread of cancer to the spine is referred to as spine metastasis. Spine metastases are a common complication of cancer and are frequently associated with significant back pain. This study is being done to help improve treatment for back pain caused by spinal metastases by comparing the effective...
What is the current status of trial NCT04375891?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 63 participants. The study started on 2020-05-22. Estimated completion is 2027-07.
What conditions does trial NCT04375891 study?
This clinical trial studies the following conditions: Oncology, Spine Metastases.
What interventions are being tested in trial NCT04375891?
The interventions under investigation include: Radiation Therapy (RADIATION), Radiofrequency Ablation (RFA) (RADIATION).
Who is sponsoring clinical trial NCT04375891?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04375891 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oncology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04375891's enrollment target sits among peer trials
63 15th of 24 higher than 8 of 24 other Oncology trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oncology trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Leading Healthy Eating and Activity Promotion Program
RECRUITING · NA
-
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
RECRUITING · NA
-
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
RECRUITING · NA
-
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI